Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Outset Medical ( (OM) ) is now available.
On May 14, 2025, Outset Medical announced the resignation of Dale E. Jones from its Board of Directors and the appointment of Kevin O’Boyle as a new board member and Chair of the Audit Committee. Mr. O’Boyle, an experienced healthcare executive with a background in capital equipment and recurring revenue business models, is expected to guide Outset through its next growth phase. His appointment follows his extensive experience on the boards of several medical device companies, enhancing Outset’s strategic positioning in the medical technology industry.
The most recent analyst rating on (OM) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Outset Medical stock, see the OM Stock Forecast page.
Spark’s Take on OM Stock
According to Spark, TipRanks’ AI Analyst, OM is a Neutral.
Outset Medical shows positive revenue growth and operational improvements, yet faces challenges in profitability and cash flow management. The stock’s positive momentum is balanced by overbought indicators, and valuation metrics are weak due to ongoing losses. The optimistic earnings call provides a positive outlook, mitigating some risks. Overall, while growth prospects exist, significant financial and market risks remain.
To see Spark’s full report on OM stock, click here.
More about Outset Medical
Outset Medical, Inc. is a medical technology company that has developed the Tablo® Hemodialysis System, a first-of-its-kind technology designed to reduce the cost and complexity of dialysis. The system is FDA cleared for use in various settings from hospitals to homes, offering a comprehensive solution that simplifies dialysis operations and enhances patient experience. The Tablo system integrates water purification and on-demand dialysate production, functioning as a mobile dialysis clinic with advanced data analytics capabilities.
Average Trading Volume: 139,525
Technical Sentiment Signal: Sell
Current Market Cap: $288.7M
Learn more about OM stock on TipRanks’ Stock Analysis page.